Jocelyn Gal

3.3k total citations · 1 hit paper
132 papers, 2.2k citations indexed

About

Jocelyn Gal is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jocelyn Gal has authored 132 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 39 papers in Cancer Research and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jocelyn Gal's work include Breast Cancer Treatment Studies (22 papers), Head and Neck Cancer Studies (15 papers) and Breast Lesions and Carcinomas (15 papers). Jocelyn Gal is often cited by papers focused on Breast Cancer Treatment Studies (22 papers), Head and Neck Cancer Studies (15 papers) and Breast Lesions and Carcinomas (15 papers). Jocelyn Gal collaborates with scholars based in France, United States and Germany. Jocelyn Gal's co-authors include Esma Saâda-Bouzid, Jean‐Michel Hannoun‐Lévi, Emmanuel Chamorey, J. Guigay, Frédéric Peyrade, Renaud Schiappa, Christophe Le Tourneau, Marie Alt, Virginia Palomar Coloma and Delphine Loirat and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Jocelyn Gal

124 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

2017 449 citations Jocelyn Gal, Christophe Le Tourneau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jocelyn Gal France	25	919	594	520	486	298	132	2.2k
Rakesh Kapoor India	24	528 0.6×	756 1.3×	328 0.6×	659 1.4×	381 1.3×	238	2.4k
Goura Kishor Rath India	25	786 0.9×	746 1.3×	435 0.8×	404 0.8×	600 2.0×	150	2.6k
Gianmauro Numico Italy	28	1.1k 1.2×	776 1.3×	399 0.8×	531 1.1×	569 1.9×	115	2.6k
Hui Zhao United States	27	822 0.9×	801 1.3×	321 0.6×	559 1.2×	491 1.6×	198	2.6k
Joshua E. Meyer United States	21	1.1k 1.2×	640 1.1×	286 0.6×	756 1.6×	279 0.9×	113	2.2k
Ladislav Pecen Czechia	26	555 0.6×	713 1.2×	175 0.3×	424 0.9×	246 0.8×	132	2.5k
Jason A. Zell United States	34	2.0k 2.1×	1.7k 2.8×	442 0.8×	618 1.3×	527 1.8×	130	3.7k
Tawee Tanvetyanon United States	32	1.7k 1.8×	1.3k 2.2×	312 0.6×	724 1.5×	721 2.4×	135	3.3k
Luigi Santoro Italy	26	679 0.7×	318 0.5×	282 0.5×	512 1.1×	160 0.5×	77	2.3k
Stephen Broderick United States	28	1.1k 1.2×	2.0k 3.4×	242 0.5×	745 1.5×	312 1.0×	84	2.7k

Countries citing papers authored by Jocelyn Gal

Since Specialization

Citations

This map shows the geographic impact of Jocelyn Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn Gal more than expected).

Fields of papers citing papers by Jocelyn Gal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyn Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn Gal. The network helps show where Jocelyn Gal may publish in the future.

Co-authorship network of co-authors of Jocelyn Gal

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyn Gal. A scholar is included among the top collaborators of Jocelyn Gal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyn Gal. Jocelyn Gal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gal, Jocelyn, et al.. (2025). De-Escalating Anticancer Treatment: Watch Your Step. Cancers. 17(15). 2474–2474. 1 indexed citations

Gal, Jocelyn, et al.. (2025). PD-L1 Expression in NSCLC: Clouds in a Bright Sky. International Journal of Molecular Sciences. 26(13). 6066–6066.

Saâda, Esma, Jocelyn Gal, Jean‐Sébastien Frenel, et al.. (2024). 62P Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed glioblastoma multiforme: PAZOGLIO trial. ESMO Open. 9. 102291–102291. 1 indexed citations

Mograbi, Baharia, et al.. (2024). Companion Tests and Personalized Cancer Therapy: Reaching a Glass Ceiling. International Journal of Molecular Sciences. 25(18). 9991–9991. 1 indexed citations

Chamorey, Emmanuel, Jean-Marc Ferrero, Hakim Mahammedi, et al.. (2024). Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 25(11). 6058–6058.

Gal, Jocelyn, Emmanuel Chamorey, Renaud Schiappa, et al.. (2023). Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors. Journal of Clinical Medicine. 12(4). 1305–1305. 8 indexed citations

Bailleux, Caroline, David Chardin, Jocelyn Gal, et al.. (2023). Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer. Cancers. 15(7). 1941–1941.

Schiappa, Renaud, Dorian Culié, Jocelyn Gal, et al.. (2023). Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record System. JCO Clinical Cancer Informatics. 7(7). e2200130–e2200130. 3 indexed citations

Gal, Jocelyn, Emmanuel Chamorey, O. Dassonville, et al.. (2023). Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes. Journal of Clinical Medicine. 12(3). 1131–1131. 3 indexed citations

10.

Gal, Jocelyn, O. Dassonville, Clair Vandersteen, et al.. (2023). Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules. European Journal of Endocrinology. 188(3). 249–257. 8 indexed citations

11.

Ferrero, Jean-Marc, Hakim Mahammedi, Gwénaëlle Gravis, et al.. (2023). Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer. Pharmaceutics. 15(2). 651–651. 3 indexed citations

12.

Aide, Nicolas, Dennis Vriens, Cornelis H. Slump, et al.. (2023). Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer. Cancers. 15(10). 2681–2681. 3 indexed citations

13.

Grosjean, Iris, Amine Belaïd, Romain K. Gherardi, et al.. (2022). Autophagopathies: from autophagy gene polymorphisms to precision medicine for human diseases. Autophagy. 18(11). 2519–2536. 25 indexed citations

14.

Gérard, Jean‐Pierre, Arthur Sun Myint, N. Barbet, et al.. (2022). Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV. Cancers. 14(5). 1313–1313. 6 indexed citations

15.

Brest, Patrick, Baharia Mograbi, Jocelyn Gal, Paul Hofman, & G. Milano. (2022). Host genetic variability and determinants of severe COVID-19. Trends in Genetics. 39(3). 169–171. 2 indexed citations

16.

Benois, Marine, Radwan Kassir, Hichem Chenaitia, et al.. (2022). Mesenchymal Stem Cells and PRP Therapy Favorize Leak Closure After Sleeve Gastrectomy in Zucker Rats. Obesity Surgery. 32(4). 1251–1260. 4 indexed citations

17.

Gal, Jocelyn, G. Milano, Patrick Brest, et al.. (2020). VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study. Pharmaceuticals. 13(11). 414–414. 7 indexed citations

18.

Cesaretti, Manuela, Jocelyn Gal, Charles Bouveyron, et al.. (2020). Accurate assessment of nonalcoholic fatty liver disease lesions in liver allograft biopsies by a smartphone platform: A proof of concept. Microscopy Research and Technique. 83(9). 1025–1031. 6 indexed citations

19.

Dugué, Audrey Emmanuelle, Marina Pulido, Sylvie Chabaud, Lisa Belin, & Jocelyn Gal. (2016). How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R Software. Clinical Cancer Research. 22(23). 5629–5635. 6 indexed citations

20.

Zangari, Joséphine, Marius Ilié, Florian Rouaud, et al.. (2016). Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition. Nucleic Acids Research. 45(7). gkw1284–gkw1284. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact